Brown Advisory’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,042
| Closed | -$9.11K | – | 1181 |
|
|
2023
Q1 | $9.11K | Hold |
1,042
| – | – | ﹤0.01% | 1203 |
|
|
2022
Q4 | $5.6K | Hold |
1,042
| – | – | ﹤0.01% | 1200 |
|
|
2022
Q3 | $9K | Hold |
1,042
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q2 | $35K | Hold |
1,042
| – | – | ﹤0.01% | 1089 |
|
|
2022
Q1 | $52K | Hold |
1,042
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q4 | $70K | Hold |
1,042
| – | – | ﹤0.01% | 1219 |
|
|
2021
Q3 | $112K | Hold |
1,042
| – | – | ﹤0.01% | 1080 |
|
|
2021
Q2 | $66K | Hold |
1,042
| – | – | ﹤0.01% | 1056 |
|
|
2021
Q1 | $63K | Hold |
1,042
| – | – | ﹤0.01% | 1067 |
|
|
2020
Q4 | $44K | Hold |
1,042
| – | – | ﹤0.01% | 1008 |
|
|
2020
Q3 | $58K | Hold |
1,042
| – | – | ﹤0.01% | 949 |
|
|
2020
Q2 | $36K | Hold |
1,042
| – | – | ﹤0.01% | 934 |
|
|
2020
Q1 | $34K | Hold |
1,042
| – | – | ﹤0.01% | 923 |
|
|
2019
Q4 | $63K | Hold |
1,042
| – | – | ﹤0.01% | 1018 |
|
|
2019
Q3 | $39K | Hold |
1,042
| – | – | ﹤0.01% | 995 |
|
|
2019
Q2 | $44K | Hold |
1,042
| – | – | ﹤0.01% | 1012 |
|
|
2019
Q1 | $89K | Buy |
+1,042
| New | +$89K | ﹤0.01% | 1286 |
|